Rare and Atypical Diabetes Network (RADIANT) Renewal
May 2022 Council
Point(s) of Contact
Ellen Leschek, M.D.; Beena Akolkar, Ph.D.; Christine Lee, M.D., M.S.
The Rare and Atypical Diabetes Network (RADIANT) is multidisciplinary group of investigators with expertise in diabetes, clinical phenotyping, genetics, metabolomics, and bioinformatics at 14 clinical centers, 5 specialized laboratories, and a data coordinating center. RADIANT is enrolling individuals and families with rare and atypical diabetes for in-depth, phenotypic and genetic analyses to help characterize new subtypes of diabetes and to provide insights on mechanisms underlying more common forms of type 2 diabetes. To date, 729 individuals have been screened and of these, 160 individuals have been found to have a new, atypical form of diabetes and were enrolled for deeper phenotyping measures and genetic analyses. Additionally, a data and biospecimen repository is being created to facilitate broader research efforts to understand heterogeneity in type 2 diabetes and to foster precision medicine efforts with more targeted diagnostics and therapeutics.